Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Equity Ratio: 2010-2025

Historic Equity Ratio for Sunshine Biopharma (SBFM) over the last 11 years, with Sep 2025 value amounting to 0.77.

  • Sunshine Biopharma's Equity Ratio fell 7.75% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year decrease of 7.75%. This contributed to the annual value of 0.77 for FY2024, which is 0.84% down from last year.
  • As of Q3 2025, Sunshine Biopharma's Equity Ratio stood at 0.77, which was down 4.35% from 0.80 recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Equity Ratio peaked at 1.00 during Q2 2022, and registered a low of -0.58 during Q1 2021.
  • For the 3-year period, Sunshine Biopharma's Equity Ratio averaged around 0.78, with its median value being 0.78 (2024).
  • In the last 5 years, Sunshine Biopharma's Equity Ratio soared by 669.70% in 2022 and then declined by 27.50% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Equity Ratio (Quarterly) stood at 0.10 in 2021, then spiked by 669.70% to 0.74 in 2022, then rose by 4.86% to 0.78 in 2023, then dropped by 0.84% to 0.77 in 2024, then declined by 7.75% to 0.77 in 2025.
  • Its Equity Ratio was 0.77 in Q3 2025, compared to 0.80 in Q2 2025 and 0.78 in Q1 2025.